All News | FDA

Advertising & Promotion

Feb 4, 2022
More States, Tribes Settle Lawsuits Over Opioid Marketing
Jan 28, 2022
OPDP Issues First Untitled Letter of 2022
Jan 21, 2022
Bill To Remove DTC Prescription Drug Advertising Deduction Introduced in US House
Jan 14, 2022
OPDP Reminds Companies in Untitled Letter That Complete Promotions Must Be Submitted
Jan 7, 2022
OPDP Adds New Division
Dec 31, 2021
Oregon Sets Temporary Rules for Sales Rep Licensing
Dec 24, 2021
District Court Allows Qui Tam Suit Over Marketing Claims and Speaker Programs To Continue
Dec 17, 2021
FDA Plans To Release Final Rule on DTC Ads in September
Dec 14, 2021
House Committee Report Critiques Pharma Business, Pricing Practices
Dec 9, 2021
Allergan Settles with New York over Opioid Marketing

Good Clinical Practice

Apr 13, 2022
Bills Requiring Drug Trial Cost Reporting Introduced
Apr 2, 2022
FDA Issues Three Final Guidances To Aid Cancer Trials
Mar 25, 2022
SACHRP: Research Enterprise Needs To Do More To Protect Non-subjects
Mar 18, 2022
OHRP Issues First Determination Letters Since 2020; Investigator Receives FDA Warning Letter
Mar 17, 2022
OIG: Device Firm’s Cost-Sharing Subsidies for Clinical Study Would Pose Only Minimal Risk of Fraud
Mar 14, 2022
FDA Permanently Debars Two Clinical Trial Site Staff Members
Mar 7, 2022
FDA BIMO Inspections Down 17% in FY 2021
Feb 25, 2022
FDA Provides Guidance on Screening and Exit Interviews in Clinical Trials
Feb 20, 2022
FDA Warning Letter Alleges Informed Consent, IRB Violations
Feb 15, 2022
Proposed Senate HELP Committee Pandemic Bill Includes Provisions To Modernize Trials

U.S. Food Labeling

Jan 21,2021
FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims
Jan 7,2021
ANPR Issued on USDA’s Oversight of Genetically Engineered Animals
Jan 7,2021
Petition Seeks Dietary Fiber Consideration for Gum Acacia
Jan 7,2021
FDA Sets New Food Labeling Uniform Compliance Date
Jan 7,2021
Supplement Firm Owner Pleads Guilty to Drug Distribution
Jan 7,2021
FDA Warns Retailer About Undeclared Allergens
Dec 23,2020
FDA Finalizes Labeling Guidance on Alternate Name for Potassium Chloride
Dec 10,2020
Court Refuses To Enjoin Oklahoma Plant-Based Meat Labeling Law; Plaintiffs Appeal
Nov 24,2020
House Passes Bill To Add Sesame to Regulated List of Allergens
Nov 12,2020
FDA Posts Draft Guidance on Voluntary Disclosure of Sesame as Allergen

FDA Regulation & Enforcement

Aug 9, 2024
FSANZ Consumer Survey Finds More Trust in Back-of-Package Labeling
Aug 7, 2024
DOJ Expands Whistleblower Opportunities in Corporate Criminal Cases Through Awards Pilot Program
Aug 2, 2024
OPDP Issues Two Untitled Letters
Jul 31, 2024
District Court: State Law Tort Claims Involving Class II De Novo Device Are Expressly Preempted
Jul 26, 2024
OPDP Research Finds Disease Awareness Ads Could Confuse Consumers on Drug Risks and Benefits
Jul 24, 2024
HHS OIG: Lack of Data Prevents Favorable Assessment of Fraud Risk Posed by Fertility Treatment Help
Jul 19, 2024
Group Offers ‘Seed Oil Free Certified’ Seal
Jul 17, 2024
Compounder Pleads Guilty, Former Sales Exec Indicted in Connection With Vet Drug Kickback Scheme
Jul 13, 2024
District Court Finds ‘Manufactured in the USA’ Label False
Jul 13, 2024
FDA To Exercise Enforcement Discretion for ‘Tailored’ Responses to Internet Misinformation

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.